Results 31 to 40 of about 45,910 (249)
The global incidence of bullous pemphigoid: a systematic review and meta‐analysis
British Journal of Dermatology, 2021 Bullous pemphigoid (BP) is an autoimmune blistering disorder that mainly affects older people. Although the disease is associated with considerable morbidity and mortality, the burden of disease worldwide is unclear.
Matty Persson +5 more
semanticscholar +1 more source
Bullous pemphigoid in a 3-month-old infant: case report and literature review of this dermatosis in childhood [PDF]
Anais Brasileiros de Dermatologia, 2013 Bullous pemphigoid is an autoimmune subepidermal blistering dermatosis that is uncommon in childhood. We report a case of a female infant, 3 months old, which presented clinical and laboratory data for the confirmatory diagnosis of bullous pemphigoid ...
Eugenio Galdino de Mendonça Reis-Filho +3 more
doaj +1 more source
Journal of Investigative Dermatology, 1985 Indirect immunofluorescence was performed on skin from 13 patients with epidermolysis bullosa (EB) (simplex, 6; junctional, 2; dystrophic, 5) to compare the expression of 3 basement membrane components, bullous pemphigoid (BP) antigen, cicatricial ...
Jo-David Fine, Jo-David Fine
semanticscholar +1 more source
Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
Frontiers in Immunology, 2021 Bullous pemphigoid (BP) is a blistering autoimmune skin disease. Omalizumab, a monoclonal antibody directed to IgE, showed a beneficial effect in treatment of recalcitrant BP in case series.
S. M. Seyed Jafari +5 more
semanticscholar +1 more source
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Acta Dermato-Venereologica, 2020 Evidence about the association of bullous pemphigoid and the risk of cancer is conflicting. Patients diagnosed with bullous pemphigoid (n = 5,739) between 2005 and 2016 were matched with a control cohort from the general population (n = 17,168) to ...
Zeyad Albadri +4 more
doaj +1 more source
Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study. [PDF]
, 2008 OBJECTIVE: To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgaris in the United Kingdom. DESIGN: Retrospective historical cohort study. SETTING: Computerised medical records from the health improvement network, a large
Fleming, KM +5 more
core +2 more sources
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an acquired autoimmune blistering dermatosis that is commonly associated with high morbidity and mortality. New-onset bullous pemphigoid following vaccinations has rarely been reported in the literature.
Vincent Wan +3 more
doaj +1 more source
Journal of the European Academy of Dermatology and Venereology, 2021 during the COVID-19 pandemics the management of immunosuppressed patients, such as those affected by autoimmune bullous diseases (AIBDs), became a matter of particular concern for healthcare systems; dissemination of sound and updated information became ...
G. Damiani +3 more
semanticscholar +1 more source
Annular bullous pemphigoid: A case report and review of literature
SAGE Open Medical Case Reports, 2022 Bullous pemphigoid is an autoimmune blistering disease that primarily affects the geriatric population. It often presents as urticarial erythematous plaques, which evolve into subepidermal blisters accompanied by pruritus.
Steffie Arès +4 more
doaj +1 more source